This inventor holds 1 USPTO granted patent. Top assignee: Alpha-9 Oncology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Megan Bumgarner: Innovator in Radiopharmaceuticals
Introduction
Megan Bumgarner is a prominent inventor based in Boston, MA. She has made significant contributions to the field of radiopharmaceuticals, showcasing her expertise and innovative spirit. With a focus on developing stable radiopharmaceutical compositions, her work has the potential to impact medical diagnostics and treatments.
Latest Patents
Megan holds a patent for "Stable Radiopharmaceutical Compositions and Uses Thereof." This patent highlights her commitment to advancing the field and improving the efficacy of radiopharmaceuticals. She has successfully secured 1 patent that reflects her innovative contributions.
Career Highlights
Megan is currently employed at Alpha-9 Oncology Inc., where she continues to push the boundaries of research and development in oncology. Her role at the company allows her to collaborate with other talented professionals in the field, further enhancing her impact on medical science.
Collaborations
Megan has worked alongside notable colleagues, including Thomas Kostelnik and Julie Rousseau. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of their projects.
Conclusion
Megan Bumgarner is a dedicated inventor whose work in radiopharmaceuticals is paving the way for advancements in medical treatments. Her contributions are invaluable to the field, and her innovative spirit continues to inspire others.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile